Hansa Biopharma Unveils its Impressive Half-Year Results for Jan-June 2023 – Join the Conference Call Today for a Business Update!

We invite you to join us on July 20th, 2023 to learn more about the success of Hansa Biopharma AB (Nasdaq Stockholm: HNSA) as we reveal our impressive interim report for January-June 2023. At 8:00 CET, the results will be released, followed at 2:00pm CET/8:00am EST by a virtual presentation and update hosted by Hansa Biopharma’s CEO, Søren Tulstrup, CCO and US President, Matthew Shaulis and CFO, Donato Spota. Don’t miss the opportunity to hear from our forward-thinking team and get the full scoop on our accomplishments!

Financial calendar and events 2023

July 18, 2023 William Blair Conference Transitioning Biotech Breakthroughs to Commercial Success (virtual)

July 20, 2023 Half-year Report for January-June 2023

Aug 23, 2023 Carnegie non-deal road show, Stockholm

Aug 24, 2023 Erik Penser Company Day, Stockholm

Aug 30-31, 2023 Cowen US non-deal road show

Sept 6-7, 2023 CITI Annual BioPharma Conference, Boston

Sept 11, 2023 HC Wainwright Annual Global Investment Conference, NYC

Sept 11-12, 2023 MorganStanley Global Healthcare Conference, NYC

Sept 14, 2023 Pareto Annual Healthcare Conference, Stockholm

Sept 14, 2023 Erik Penser Company Day, Malmö

Oct 2, 2023 Redeye: Autoimmune and inflammatory disease, Stockholm

Oct 12, 2023 Redeye: Afterwork, Malmö

Oct 19, 2023 Interim Report for January-September 2023

Nov 21, 2023 SEB Healthcare Seminar 2023, Stockholm

Nov 22, 2023 Ökonomisk Ugebrev Life Science Event, Copenhagen

Leave a Comment